PREVALENCE OF SICKLE CELL ANEMIA IN YOUTH BY COST EFFECTIVE STRATEGY ALONG WITH HPLC
DOI:
https://doi.org/10.55766/sujst-2023-03-e03091Keywords:
Haemoglobinopathies, HPLC, Sickle cell, Sickling test, Solubility testAbstract
This study aimed to determine the prevalence of sickle cell disease among students of Anand People’s Medicare Society (APMS) using cost-effective screening methods and confirming the results with high-performance liquid chromatography (HPLC). A total of 395 students from Anand, Gujarat, were screened using the sickling test and solubility test as primary screening methods. Haemoglobinopathies carriers were diagnosed and confirmed using HPLC at the Indian Red Cross Society, State Branch in Ahmedabad. Complete hemogram analysis was performed, and the results were tabulated and analyzed. The results indicated that HPLC exhibited 100% sensitivity, specificity, and accuracy, while the sickling test demonstrated a sensitivity of 66.66%, specificity of 97.90%, and accuracy of 97.21%. The solubility test showed a sensitivity of 53.84%, specificity of 96.85%, and accuracy of 95.44%. HPLC had a 100% positive predictive value (PPV) and negative predictive value (NPV), whereas the sickling test had a PPV of 55.55% and NPV of 99.20%. The solubility test yielded a PPV of 36.84% and NPV of 98.40%. In conclusion, the sickling test and solubility test are cost-effective and easily conducted, with the sickling test providing more reliable results with higher sensitivity and specificity compared to the solubility test. HPLC is considered the gold standard test for screening.
References
Ahmad, M.M., Gupta, H.N., Shinde, D.S., and Ruparel, N.D. (2018). The Prevalence and Severity of Sickle Cell Disease in Amravati District of Maharashtra. Indian Journal of Pharmacy Practice, 11(4):205. https://doi.org/10.5530/ijopp.11.4.42
Arishi, W.A., Alhadrami, H.A., and Zourob, M. (2021). Techniques for the Detection of Sickle Cell Disease: A Review. Micromachines, 12(5):519. https://doi.org/10.3390/mi12050519
Bajaj, P. and Gupta, A. (2020). Spectrum of Hemoglobinopathies Diagnosed by High Performance Liquid Chromatography at a Tertiary Care Centre: An Observational Study. MVP Journal of Medical Sciences, 1:240-5. https://doi.org/10.18311/mvpjms/2020/v7i2/24503
Datar, S., Poflee, S., and Shrikhande, A. (2015). Premarital screening of college students for carrier detection in thalassemia and sickle cell disease. International Journal of Medical Science and Public Health, 3(15):420-3. https://doi.org/10.5455/ijmsph.2015.1812201469
Delux, V. G., & Sarika, M. (2018). Evaluation of sickling and solubility tests and peripheral blood smear method for screening of sickle cell disease. MedPulse International Journal of Pathology, 7(3):118-122.
Desai, G., Dave, K.K., Banerjee, S., Babaria, P., and Gupta, R. (2016). Initial outcomes of a comprehensive care model for sickle cell disease among a tribal population in rural western India. International Journal of Community Medicine and Public Health, 3(5):1,282-1,287.
Ghosh, K., Colah, R., Manglani, M., Choudhry, V.P., Verma, I., Madan, N., Saxena, R., Jain, D., Marwaha, N., Das, R., and Mohanty, D. (2014). Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian Journal of Human Genetics, 20(2):101. https://doi.org/10.4103/0971-6866.142841
Jain, R. and Saxena, S. (2020). The efficacy and reliability of Solubility test followed by High-Performance Liquid Chromatography (HPLC) for sickle cell disorders in Gujarat- An original research article. Tropical Journal of Pathology and Microbiology, 6(2):198-203. https://doi.org/10.17511/jopm.2020.i02.13
Kohne, E. (2011). Hemoglobinopathies: Clinical Manifestations, Diagnosis, and Treatment. Deutsches Ärzteblatt International, 108(31-32):532. https://doi.org/10.3238/arztebl.2011.0532
Mangla, A., Ehsan, M., Agarwal, N., Maruvada, S., and Doerr, C. (2021). Sickle Cell Anemia (Nursing). In StatPearls [Internet] 19. StatPearls Publishing.
Mujumdar, M. and Mujumdar, V. (2020). Study of Sickle Cell Anemia in Tribal Area of Dahod Region of Gujarat. International Archives of Biomedical and Clinical Research, 6(1):PA17-PA20.
Obeagu, E.I., Ochei, K.C., Nwachukwu, B.N., and Nchuma, B.O. (2015). Sickle cell anaemia: a review. Scholars Journal of Applied Medical Sciences, 3(6B):2,244-2,252.
Patel, A.P., Naik, M.R., Shah, N.M., Sharma, N.P., and Parmar, P.H. (2012). Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening program. National Journal of Community Medicine, 3:112-117.
Rajput, J.H., Naik, J.P., and Italia, Y.M. (2015). Clinical Evaluation and Enhancement of Dithionite tube turbidity (DTT) test reagents used for field screening of Sickle Haemoglobin (HbS). International Journal of Pharmacy & Life Sciences, 6(2):1,292-1,296.
Rees, D.C., Williams, T N., and Gladwin, M.T. (2010). Sickle-cell disease. The Lancet, 376(9757):2,018-2,031. https://doi.org/10.1016/S0140-6736(10)61029-X
Novartis A.G. (2021). Sickle cell disease know more do more together [Homepage on the internet]. USA: The Association; 2021 122161; [about 2 screens]. Available from: https://www.notaloneinsicklecell.com/GlobalImpact-Of-SCD/ [Accessed: July 12, 2023].
World Health Organization. (2021). Sickle cell disease. Retrieved from https://www.afro.who.int/health-topics/ sickle-cell-disease
Yadav, R., Lazarus, M., Ghanghoria, P., Singh, M. P., Gupta, R. B., Kumar, S., Sharma, R. K., & Shanmugam, R. (2016). Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals. Hematology, 21(9):558-563. https://doi.org/10.1080/10245332.2016.1148893
